Table 2.
NGF concentrations (pg/g) | ||||
Healthy control | Healthy EA | PCO control | PCO EA | |
Ovary | 294.85 ± 17.00 | 265.79 ± 20.99 | 479.77 ± 26.86a | 385.34 ± 12.26b |
Adrenal gland | 102.42 ± 26.14 | 119.97 ± 51.81 | 98.82 ± 12.46 | 94.42 ± 14.32 |
Spinal cord | 867.36 ± 65.52 | 1600.59 ± 360.03 | 1351.26 ± 220.82 | 1081.94 ± 193.72 |
NGF mRNA expression (O.D. 450/690) | ||||
Ovary | 1.02 ± 0.19 | 1.10 ± 0.2 | 0.35 ± 0.06c | 0.45 ± 0.15 |
Adrenal gland | 0.41 ± 0.06 | 0.51 ± 0.07 | 0.32 ± 0.06 | 0.37 ± 0.05 |
Spinal cord | 0.71 ± 0.09 | 1.15 ± 0.34 | 0.57 ± 0.08 | 1.12 ± 0.29 |
a p < 0.001 when the PCO control group were compared with the healthy control group and healthy group receiving EA. b p < 0.05 when the PCO group receiving EA were compared with the PCO control group. c p < 0.001 when the PCO control group were compared with the healthy control group and the healthy group receiving EA.